Aragen Life Sciences is a leading Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end integrated and standalone solutions for small and large molecules. From concept to commercial, we transform your ideas into solutions for better health for humans, animals and plants.
Established in 2001, we operate through a global network of six sites with a team of 4200+ employees including 450+ PhDs. Our expertise and experience have enabled over 400+ customers in advancing their research programs from discovery through commercialization.
Aragen’s innovative mindset, infrastructure, flexible business models have enabled us to serve large pharma or biotech, agrochemical, animal health and performance chemical industries globally. Our purpose, ‘In every molecule is the possibility for better health’ motivates us to drive the success of your programs, so that we can together transform hope into
health for millions of people around the world.
We place equal efforts and focus on every program, irrespective of the size of the project or the customer, working as an extension of our client’s R&D team, taking full ownership of their program.
Our rich talent pool of scientific professionals and state-of-the-art facilities provide us with the expertise and capabilities to drive innovation for our customers.
We collaborate but do not compete. We are a pure-play service provider and our goal is to partner with our customers in their pursuit to deliver better health solutions. This ‘services-only’ approach – with no internal programs or stake in the IP assets of other companies – has helped us forge long-standing partnerships from discovery through development.
As we advance our client’s R&D project, the safety of our people, the
well-being of our communities, and the protection of our environment are integral to our responsibility as an organization. We foster a proactive culture of safe behavior and risk mitigation and are working on developing a sustainable green supply chain.
